Profile photo Tom Snijders

Tom Snijders

Associate Professor - medical

Strategic program(s):

Biography

T.J. (Tom) Snijders, PhD, completed his medical studies and his Neurology residency in the UMC Utrecht. During his training, he obtained a PhD-degree in the field of chronic pain medicine. He sub-specialized in Neuro-oncology during his residency.

Since 2011, he works as a neurologist and assistant professor in the UMC Utrecht. His practice encompasses all aspects of neuro-oncological patient care. His scientific work focuses on primary brain tumors, specifically gliomas. He is the co-coordinator, with prof. Elly Hol, of the Disease Area Neuro-oncology of the UMC Utrecht Brain Center.  He is co-supervisor of 5 completed or ongoing PhD-trajectories. He is also involved in providing and evaluating experimental treatments (international clinical trials) in the UMC Utrecht.

Research interests:

  • Validation and innovation of imaging techniques for brain tumors, including MRI-scans and PET-scans
  • Pseudoprogression in glioma and other brain tumors
  • Cognitive symptoms in glioma patients
  • Epilepsy due to brain tumors
  • Liquid biopsy in primary brain tumors
  • Focused Ultrasound and blood-brain-barrier disruption for brain tumor treatment
  • The multidisciplinary Team Neuro-Oncology of the UMC Utrecht aims to provide patients with the most recent innovative (experimental) treatments for brain tumors as part of clinical studies.

Research groups

Clinical and translational neuro-oncology

Research aim

We aim to improve treatments and clinical outcomes of patients with gliomas and other brain tumors, by combining expertise from oncobiology, neuropsychology, imaging, surgical & clinical neurology, and palliative care.

Go to group

Recent publications

Ultra-hypofractionated versus conventional chemoradiation for newly diagnosed glioblastoma Anouk M de Jong, Arthur T J van der Boog, Gerda Wester, Daniëlle B P Eekers, Tom C G Budiharto, Tom Rozema, Frank J Lagerwaard, Anna M E Bruynzeel, Crystal de Groot, Matthijs van der Meulen, Fia Cialdella, Jan-Willem Dankbaar, Jeroen Hendrikse, Karin E Kleynen, An Claes, Mariëlle E P Philippens, Ernst J Smid, Filip Y F L de Vos, Peter S N van Rossum, Pierre A Robe, Szabolcs David, Tom J Snijders, Joost J C Verhoeff
Radiotherapy and Oncology, 2026, vol. 223
Quantitative MRI in Radiotherapy: First observations on T1/T2/conductivity/ADC/APT variations in two brain cancer patients Stefano Mandija, Martin Schilder, Thierry Meerbothe, Edwin Versteeg, Oscar van der Heide, Alessandro Sbrizzi, Evita Wiegers, Tom Snijders, Thomas Willigenburg, Karin Kleynen, Ernst Smid, An Claes, Cornelis van den Berg
2026
Patient perspectives on diagnostic uncertainty and novel diagnostic tests in neuro-oncology Veerle J. Ruijters, Marloes M. Bauer, Nelleke Tolboom, Tatjana Seute, Leonie N.C. Visser, Tom J. Snijders
Neuro-Oncology Practice, 2026, vol. 13, p.733-742
Exploring brain-glioma interaction Eva A Krijnen, Emma van Kessel, Angelika Mühlebner, Sven van Kempen, Wim Van Hecke, Martine J E van Zandvoort, Pierre A Robe, Tom J Snijders
Neuro-oncology advances, 2026, vol. 8
Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS) Josephus L M van Rooij, Peter H Wessels, Johanna M Niers, Jacoline E C Bromberg, Johanna M M Gijtenbeek, Rick van Haastert, Henk J T Ruven, Bob Meek, Marcel M Verbeek, Nienke Solleveld-Westerink, Wendy W J de Leng, Angelika Mühlebner, Anton W Langerak, Sharon Berendsen, Edward F Knol, Hanna van Alkemade, Tatjana Seute, Monique C Minnema, Stefan Nierkens, Tom J Snijders
The Lancet. Haematology, 2026, vol. 13, p.e376-e385
Postoperative ischemia and neurological deficits after glioma resection Arthur T.J. van der Boog, Eva E. van Grinsven, Matea Rados, Tom J. Snijders, Joost J.C. Verhoeff, Pierre A. Robe
Neuro-Oncology Practice, 2026, vol. 13, p.452-464

External positions

editorial board member - editorial work & peer review - Neuro Oncology Practice

reviewer board member - peer review - MDPI Cancers (Basel)

member (ongoing), steering committee member (2021-2024), imaging committee member (2018-2024), - organization and planning of scientific research - EORTC Brain Tumor group

Committee Member - richtlijn opstellen/onderhouden - Task Force on Bing Neel Syndrome

Guideline committee ‘Intracranial meningioma', member (2012-2015), chairperson (since 2023) - writing a guideline, leading the team - Kennisinstituut/NVN

Chairperson/chief (until 2023), member (since 2023) - writing and editing medical information on website; answering questions from kanker.nl - Editorial board (‘redactieraad’) of Hersentumor.nl